Reply To: Traders Market Weekly: Fed, Inflation and Profit Warnings


Akero Therapeutics (AKRO 23.47, +11.20, +91.28%): In Akero Therapeutics’ Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks
Peloton (PTON 11.18, +0.13, +1.18%): announces leadership changes, including resignation of Executive Chair John Foley, who co-founded the company; appoints Karen Boone as Chairperson of the Board, who previously served as President and CFO of Restoration Hardware
Planet Labs (PL 6.07, +0.65, +11.99%): misses by $0.04, beats on revs; guides Q3 revs in-line; guides FY23 revs above consensus
Rent the Runway (RENT 3.7300, -1.20, -24.34%): beats by $0.07, beats on revs; guides Q3 revs below consensus; guides FY23 revs below consensus; announces restructuring plan to reduce costs, including a 24% workforce reduction
Oracle (ORCL 78.42, +1.34, +1.74%): misses by $0.04, reports revs in-line; guides Q2 (Nov) adjusted EPS below consensus, revs below consensus largely due to FX headwinds; announces that MySQL HeatWave is now available on AWS
Catalyst Pharma (CPRX 16.30, +1.15, +7.59%): will replace Mantech International Corp. (MANT) in the S&P SmallCap 600 effective prior to the opening of trading on September 15
Braze (BRZE 41.49, -2.09, -4.80%): beats by $0.04, beats on revs; guides Q3 EPS below consensus, revs in-line; guides FY23 EPS above consensus, revs in-line
Twitter (TWTR 41.71, +0.30, +0.72%): Twitter shareholders approve sale to Elon Musk
AppLovin (APP 29.27, +0.76, +2.67%): confirms that it does not intend to submit another proposal to combine with Unity Software and has withdrawn its initial proposal
Eastman Chemical (EMN 93.94, -0.93, -0.98%): sees Q3 EPS well below consensus